Chengdu Easton (China) Today
| 688513 Stock | 32.73 0.22 0.67% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Chengdu Easton is trading at 32.73 as of the 28th of November 2024, a 0.67 percent decrease since the beginning of the trading day. The stock's open price was 32.95. Chengdu Easton has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Chengdu Easton Biopharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of June 2024 and ending today, the 28th of November 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Chengdu Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chengdu Easton's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chengdu Easton or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chengdu Easton Biopharmaceuticals (688513) is traded on Shanghai Stock Exchange in China and employs 1,400 people. Chengdu Easton is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.75 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chengdu Easton's market, we take the total number of its shares issued and multiply it by Chengdu Easton's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chengdu Easton Bioph operates under Biotechnology sector and is part of Health Care industry. The entity has 176.53 M outstanding shares.
Chengdu Easton generates positive cash flow from operations, but has no cash available
Check Chengdu Easton Probability Of Bankruptcy
Ownership AllocationChengdu Easton holds a total of 176.53 Million outstanding shares. Chengdu Easton Biopharmaceuticals shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 79.96 percent of Chengdu Easton Bioph outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Chengdu Ownership Details
Chengdu Easton Bioph Risk Profiles
Although Chengdu Easton's alpha and beta are two of the key measurements used to evaluate Chengdu Easton's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.02 | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.44 | |||
| Risk Adjusted Performance | (0.02) |
Chengdu Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chengdu Easton without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Chengdu Easton Corporate Management
Elected by the shareholders, the Chengdu Easton's board of directors comprises two types of representatives: Chengdu Easton inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chengdu. The board's role is to monitor Chengdu Easton's management team and ensure that shareholders' interests are well served. Chengdu Easton's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chengdu Easton's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zheng Guan | Deputy Technician | Profile | |
| Yiou Wang | Board Secretary | Profile | |
| Chen Hong | Deputy Technician | Profile | |
| Avinash Mane | Chief Technician | Profile | |
| Tian Lin | Deputy Technician | Profile | |
| Shuyun Li | Board Secretary | Profile | |
| Xingyao Song | Deputy Manager | Profile |
Other Information on Investing in Chengdu Stock
Chengdu Easton financial ratios help investors to determine whether Chengdu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chengdu with respect to the benefits of owning Chengdu Easton security.